No Data
No Data
hubei guangji pharmaceutical (000952.SZ): intends to pre-list and transfer 90% equity of its holding subsidiary hubei guangji pharmaceutical technology co., ltd.
On September 20th, Guangji Pharmaceutical (000952.SZ) announced that in order to effectively utilize asset resources and realize asset value, the company plans to transfer 90% equity of its holding subsidiary Hubei Guangji Medical Technology Co., Ltd. through pre-listing transfer on Shanghai United Property Exchange in accordance with relevant regulations on state-owned property rights management. The transfer price will be based on the evaluation results filed after the formal listing transfer and will be determined after the corresponding approval procedures of the company are completed.
Guangji Pharmaceutical: Semi-Annual Report 2024
Guangji Pharmaceutical: 2024 Semi-Annual Report Summary
Hubei Guangji Pharmaceutical (000952.SZ) released its performance for the first half of the year, with a net loss of 107 million yuan.
Hubei Guangji Pharmaceutical (000952.SZ) has released its 2024 interim report, during the reporting period, the company achieved revenue...
Hubei Guangji Pharmaceutical: 2024 Interim Performance Forecast
Guangji Pharmaceutical (000952.SZ): The company uses microbial fermentation to produce vitamin B2
Gelonghui, May 9 | Guangji Pharmaceutical (000952.SZ) said on the investor interactive platform that the company uses microbial fermentation to produce vitamin B2.
No Data
No Data